Publications by authors named "H Miyagi"
Purpose: This study aimed to identify surgical site infection (SSI) risk factors after anal reconstruction surgery in patients with anorectal malformations (ARMs).
Methods: This retrospective analysis from January 2013 to December 2022, including all pediatric surgical facilities in Hokkaido, Japan, examined consecutive patients with ARMs, excluding cloacal cases, regarding perioperative and SSI factors during their initial anal reconstruction surgeries.
Results: This study involved 157 cases of major clinical groups and 7 cases of rare/regional variants, among whom 4% developed SSIs.
Managing medical devices efficiently was a challenge, especially with manual methods proving error-prone amid staff shortages. To overcome these issues, we developed a novel IoT powerstrip device for tracking usage and location. This helps monitor devices in real-time, empowering more efficient management and utilization.
View Article and Find Full Text PDFObjective: To quantify the risk of long-term post-radical prostatectomy (RP) erectile dysfunction (ED) in men with diabetes mellitus (DM).
Methods: We included men who underwent RP and were followed for ≥24 months at our institution; men were excluded if they received androgen deprivation therapy or radiation therapy. Erectile function recovery (EFR) was assessed using the International Index of Erectile Function (IIEF) Erectile Function Domain (EFD) score pre-RP and serially during follow-up.
Article Synopsis
- The review focuses on the emerging role of urinary tumor DNA (utDNA) in diagnosing, monitoring, and treating bladder cancer, emphasizing its potential for personalized care.
- Recent studies suggest that utDNA is a highly effective biomarker, particularly in the early stages of bladder cancer, offering better sensitivity and more detailed genetic insights compared to traditional methods like urine cytology.
- The promise of utDNA lies in its ability for non-invasive and real-time assessment of tumor biology, indicating that future clinical trials could transform how bladder cancer is managed and treated.
Penile squamous cell carcinoma (PSCC) is a rare and deadly malignancy. Therapeutic advances have been stifled by a poor understanding of disease biology. Specifically, the immune microenvironment is an underexplored component in PSCC and the activity of immune checkpoint inhibitors observed in a subset of patients suggests immune escape may play an important role in tumorigenesis.
View Article and Find Full Text PDF